Search
Selected Filter
Displaying 1–10 of 578 news results
-
Research News
Cell therapy DSP-3077 is in Phase 1/2a clinical trials
-
Tarsus plans to purchase Alkeus, developer of emerging Stargardt treatment
Research NewsDeal marks another step as gildeuretinol advances towards patients
-
PRIMA retinal implant restores sight in patients with geographic atrophy from AMD
Research NewsProduct launched in Europe, U.S. approval in progress
-
FDA accepts new drug application, prioritizes review for potential Stargardt treatment
Research NewsBelite Bio’s tinlarebant could become the first-ever approved treatment for Stargardt disease
-
Summary of the 11th Annual Retinal Therapeutics Innovation Summit
Research NewsThe 11th annual Retinal Therapeutics Innovation Summit featured 25 presentations from industry professionals worldwide and more than 400 attendees.
-
Advocacy Foundation News
Biomedical research grants should be awarded based on scientific peer review
-
Sepul Bio completes clinical trial enrollment for its USH2A retinitis pigmentosa treatment
Research NewsUltevursen from Sepul Bio progresses through phase 2b safety and efficacy clinical trial
-
FDA approves Lumvoa, a new treatment for thyroid eye disease
Research NewsApproval gives patients an additional option to manage TED symptoms
-
Belite Bio Submits New Drug Application to FDA for its Stargardt Treatment
Research NewsTinlarebant becomes first Stargardt treatment submitted to FDA for approval
-
Recording Available: Insights Forum | Wednesday, June 24, 2026
Foundation NewsThe Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the blinding diseases community. The call took place on June 24, 2026.
